XML 38 R29.htm IDEA: XBRL DOCUMENT v3.22.2.2
Net loss per share (Tables)
9 Months Ended
Sep. 30, 2022
Net loss per share  
Schedule of basic and diluted net loss per share

The following table sets forth the computation of the basic and diluted net loss per share attributable to common stockholders (in thousands, except for per share amounts):

Three months ended September 30, 

Nine months ended September 30, 

    

2022

    

2021

    

2022

    

2021

Numerator:

 

  

 

  

 

  

 

  

Net loss

$

(18,280)

$

(20,040)

$

(52,604)

$

(54,430)

Denominator:

 

 

 

 

Weighted-average common shares outstanding, basic and diluted

54,733,709

29,896,426

49,403,999

29,837,389

Weighted-average Series A convertible preferred shares outstanding, basic and diluted, presented as if converted into common stock(1)

1,697,000

2,978,000

1,697,000

2,978,000

Weighted-average Series A-1 convertible preferred shares outstanding, basic and diluted, presented as if converted into common stock(1)

15,800,000

12,153,846

Total number of shares used to calculate net loss per share, basic and diluted

 

72,230,709

 

32,874,426

 

63,254,845

 

32,815,389

Net loss per share, basic and diluted

$

(0.25)

$

(0.61)

$

(0.83)

$

(1.66)

(1) Series A and Series A-1 convertible preferred stock are participating securities that have substantially the same terms and features as the Company’s common stock. Series A and Series A-1 convertible preferred stock is therefore included in the weighted-average number of shares outstanding to calculate net loss per share, basic and diluted as if converted in common stock. Each share of Series A and Series A-1 convertible preferred stock is independently convertible into 1,000 shares of common stock. 1,697,000 shares of the Company’s common stock are issuable upon conversion of Series A convertible preferred stock and 15,800,000 shares of the Company’s common stock are issuable upon conversion of Series A-1 convertible preferred stock (see Note 9).

Schedule of potentially dilutive securities that were not included in the diluted per share calculations

Three and nine months ended September 30, 

    

2022

    

2021

Options issued and outstanding

 

6,016,997

4,226,857

Unvested restricted stock units

9,746

Total

 

6,016,997

 

4,236,603